These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31160317)

  • 1. Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.
    Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):862-872. PubMed ID: 31160317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
    Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M;
    Diabetes Care; 2018 Jan; 41(1):163-170. PubMed ID: 29079715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
    Ninomiya T; Perkovic V; de Galan BE; Zoungas S; Pillai A; Jardine M; Patel A; Cass A; Neal B; Poulter N; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Macmahon S; Chalmers J;
    J Am Soc Nephrol; 2009 Aug; 20(8):1813-21. PubMed ID: 19443635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
    Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M
    Am J Kidney Dis; 2021 Sep; 78(3):350-360.e1. PubMed ID: 33895181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    ; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
    JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage.
    Sosner P; Hulin-Delmotte C; Saulnier PJ; Cabasson S; Gand E; Torremocha F; Piguel X; Miot A; Maréchaud R; Herpin D; Ragot S; Hadjadj S;
    Am Heart J; 2015 Jan; 169(1):108-14.e7. PubMed ID: 25497255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
    JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
    Clase CM; Gao P; Tobe SW; McQueen MJ; Grosshennig A; Teo KK; Yusuf S; Mann JF;
    Ann Intern Med; 2011 Mar; 154(5):310-8. PubMed ID: 21357908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.
    Oshima M; Toyama T; Hara A; Shimizu M; Kitajima S; Iwata Y; Sakai N; Furuichi K; Haneda M; Babazono T; Yokoyama H; Iseki K; Araki SI; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Makino H; Wada T
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34193460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.